These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 5774371)
1. [Complications and dangers of hallucinogens. Cytopharmacologic aspects]. Nosal G Laval Med; 1969 Jan; 40(1):48-55. PubMed ID: 5774371 [No Abstract] [Full Text] [Related]
2. Drugs in pregnancy and their effects on pre- and postnatal development. Kelsey FO Res Publ Assoc Res Nerv Ment Dis; 1973; 51():233-43. PubMed ID: 4590403 [No Abstract] [Full Text] [Related]
3. [LSD-25 and genetic abnormalities]. Berger R Presse Med (1893); 1971 Oct; 79(41):1779-80. PubMed ID: 5119025 [No Abstract] [Full Text] [Related]
4. [Endangering the human genotype through drugs]. Gebhart E Munch Med Wochenschr; 1973 Jul; 115(27):1237-43. PubMed ID: 4740751 [No Abstract] [Full Text] [Related]
5. Review of the evidence and qualifications regarding the effects of hallucinogenic drugs on chromosomes and embryos. Houston BK Am J Psychiatry; 1969 Aug; 126(2):251-4. PubMed ID: 5804812 [No Abstract] [Full Text] [Related]
6. [Do hallucinogens cause chromosomal defects and abnormalities?]. Eberle P Nervenarzt; 1973 Jun; 44(6):281-4. PubMed ID: 4198823 [No Abstract] [Full Text] [Related]
7. [Toxicology of cyclamates]. Göttinger E Wien Med Wochenschr; 1970 Jun; 120(25):464-5. PubMed ID: 5518001 [No Abstract] [Full Text] [Related]
8. Effect of marsilin on the behavioural and other changes in the central nervous system induced by psychotropic drugs. Dey PK; Chatterjee BK Indian J Exp Biol; 1966 Apr; 4(2):99-100. PubMed ID: 5942509 [No Abstract] [Full Text] [Related]
9. [Genetic counseling in neurosurgical diseases (author's transl)]. Takeshita K No Shinkei Geka; 1980 Mar; 8(3):211-9. PubMed ID: 6445514 [No Abstract] [Full Text] [Related]
11. Possible genetic effects of some contraceptives. Matsunaga E Australas Nurses J; 1973 Jan; 2(19):9 passim. PubMed ID: 4486781 [No Abstract] [Full Text] [Related]
12. Association of chromosome 4 abnormalities with ethylnitrosourea-induced neuro-oncogenesis in the rat. Haag MM; Soukup SW Cancer Res; 1984 Feb; 44(2):784-90. PubMed ID: 6692377 [TBL] [Abstract][Full Text] [Related]
13. [Late perturbations in central nervous system compatible with life. I. Decline of embryonic capacity in the rat by injection of heterospecific antibodies]. Auroux M; Alnot MO; Jouvensal C C R Seances Soc Biol Fil; 1967; 161(10):1917-22. PubMed ID: 4234169 [No Abstract] [Full Text] [Related]
14. [Placental transport of the lysergic acid D-diethylamide (LSD-25)]. Egozcue J Acta Obstet Ginecol Hisp Lusit; 1969 Feb; 17(2):135-46. PubMed ID: 5795736 [No Abstract] [Full Text] [Related]
15. [Neurochemical aspect of hallucinogens]. Sourkes TL Laval Med; 1969 Jan; 40(1):42-3. PubMed ID: 5774369 [No Abstract] [Full Text] [Related]
16. Leukaemia and L.S.D. Br Med J; 1969 Jun; 2(5660):775-6. PubMed ID: 5784605 [No Abstract] [Full Text] [Related]
18. [Contribution to the study of the central effects of hallucinogenic and psychotomimetic medicines]. Longo VG Actual Neurophysiol (Paris); 1967; 7():203-16. PubMed ID: 6043096 [No Abstract] [Full Text] [Related]
19. L.S.D. and chromosomes. Br Med J; 1967 Oct; 4(5572):124-5. PubMed ID: 6053973 [No Abstract] [Full Text] [Related]
20. [Neuropsychiatric aspects of complications and dangers of the use of hallucinogens]. Labrie J Laval Med; 1969 Jan; 40(1):70-3. PubMed ID: 5774376 [No Abstract] [Full Text] [Related] [Next] [New Search]